Global Mental Disorder Treatment Market Insights, Forecast to 2028

SKU ID :QYR-20456174 | Published Date: 10-Mar-2022 | No. of pages: 110
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Mental Disorder Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Medications 1.2.3 Self-help Therapies 1.3 Market by Application 1.3.1 Global Mental Disorder Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Depression 1.3.3 Bipolar Disorder 1.3.4 Schizophrenia 1.3.5 Dementia 1.3.6 Post-traumatic Stress Disorder 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Mental Disorder Treatment Market Perspective (2017-2028) 2.2 Mental Disorder Treatment Growth Trends by Region 2.2.1 Mental Disorder Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Mental Disorder Treatment Historic Market Size by Region (2017-2022) 2.2.3 Mental Disorder Treatment Forecasted Market Size by Region (2023-2028) 2.3 Mental Disorder Treatment Market Dynamics 2.3.1 Mental Disorder Treatment Industry Trends 2.3.2 Mental Disorder Treatment Market Drivers 2.3.3 Mental Disorder Treatment Market Challenges 2.3.4 Mental Disorder Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Mental Disorder Treatment Players by Revenue 3.1.1 Global Top Mental Disorder Treatment Players by Revenue (2017-2022) 3.1.2 Global Mental Disorder Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Mental Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Mental Disorder Treatment Revenue 3.4 Global Mental Disorder Treatment Market Concentration Ratio 3.4.1 Global Mental Disorder Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Mental Disorder Treatment Revenue in 2021 3.5 Mental Disorder Treatment Key Players Head office and Area Served 3.6 Key Players Mental Disorder Treatment Product Solution and Service 3.7 Date of Enter into Mental Disorder Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Mental Disorder Treatment Breakdown Data by Type 4.1 Global Mental Disorder Treatment Historic Market Size by Type (2017-2022) 4.2 Global Mental Disorder Treatment Forecasted Market Size by Type (2023-2028) 5 Mental Disorder Treatment Breakdown Data by Application 5.1 Global Mental Disorder Treatment Historic Market Size by Application (2017-2022) 5.2 Global Mental Disorder Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Mental Disorder Treatment Market Size (2017-2028) 6.2 North America Mental Disorder Treatment Market Size by Type 6.2.1 North America Mental Disorder Treatment Market Size by Type (2017-2022) 6.2.2 North America Mental Disorder Treatment Market Size by Type (2023-2028) 6.2.3 North America Mental Disorder Treatment Market Share by Type (2017-2028) 6.3 North America Mental Disorder Treatment Market Size by Application 6.3.1 North America Mental Disorder Treatment Market Size by Application (2017-2022) 6.3.2 North America Mental Disorder Treatment Market Size by Application (2023-2028) 6.3.3 North America Mental Disorder Treatment Market Share by Application (2017-2028) 6.4 North America Mental Disorder Treatment Market Size by Country 6.4.1 North America Mental Disorder Treatment Market Size by Country (2017-2022) 6.4.2 North America Mental Disorder Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Mental Disorder Treatment Market Size (2017-2028) 7.2 Europe Mental Disorder Treatment Market Size by Type 7.2.1 Europe Mental Disorder Treatment Market Size by Type (2017-2022) 7.2.2 Europe Mental Disorder Treatment Market Size by Type (2023-2028) 7.2.3 Europe Mental Disorder Treatment Market Share by Type (2017-2028) 7.3 Europe Mental Disorder Treatment Market Size by Application 7.3.1 Europe Mental Disorder Treatment Market Size by Application (2017-2022) 7.3.2 Europe Mental Disorder Treatment Market Size by Application (2023-2028) 7.3.3 Europe Mental Disorder Treatment Market Share by Application (2017-2028) 7.4 Europe Mental Disorder Treatment Market Size by Country 7.4.1 Europe Mental Disorder Treatment Market Size by Country (2017-2022) 7.4.2 Europe Mental Disorder Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Mental Disorder Treatment Market Size (2017-2028) 8.2 Asia-Pacific Mental Disorder Treatment Market Size by Type 8.2.1 Asia-Pacific Mental Disorder Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Mental Disorder Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Mental Disorder Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Mental Disorder Treatment Market Size by Application 8.3.1 Asia-Pacific Mental Disorder Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Mental Disorder Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Mental Disorder Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Mental Disorder Treatment Market Size by Region 8.4.1 Asia-Pacific Mental Disorder Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Mental Disorder Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Mental Disorder Treatment Market Size (2017-2028) 9.2 Latin America Mental Disorder Treatment Market Size by Type 9.2.1 Latin America Mental Disorder Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Mental Disorder Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Mental Disorder Treatment Market Share by Type (2017-2028) 9.3 Latin America Mental Disorder Treatment Market Size by Application 9.3.1 Latin America Mental Disorder Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Mental Disorder Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Mental Disorder Treatment Market Share by Application (2017-2028) 9.4 Latin America Mental Disorder Treatment Market Size by Country 9.4.1 Latin America Mental Disorder Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Mental Disorder Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Mental Disorder Treatment Market Size (2017-2028) 10.2 Middle East & Africa Mental Disorder Treatment Market Size by Type 10.2.1 Middle East & Africa Mental Disorder Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Mental Disorder Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Mental Disorder Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Mental Disorder Treatment Market Size by Application 10.3.1 Middle East & Africa Mental Disorder Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Mental Disorder Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Mental Disorder Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Mental Disorder Treatment Market Size by Country 10.4.1 Middle East & Africa Mental Disorder Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Mental Disorder Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan Plc 11.1.1 Allergan Plc Company Details 11.1.2 Allergan Plc Business Overview 11.1.3 Allergan Plc Mental Disorder Treatment Introduction 11.1.4 Allergan Plc Revenue in Mental Disorder Treatment Business (2017-2022) 11.1.5 Allergan Plc Recent Developments 11.2 Eli Lilly and Company 11.2.1 Eli Lilly and Company Company Details 11.2.2 Eli Lilly and Company Business Overview 11.2.3 Eli Lilly and Company Mental Disorder Treatment Introduction 11.2.4 Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2017-2022) 11.2.5 Eli Lilly and Company Recent Developments 11.3 VistaGen Therapeutics 11.3.1 VistaGen Therapeutics Company Details 11.3.2 VistaGen Therapeutics Business Overview 11.3.3 VistaGen Therapeutics Mental Disorder Treatment Introduction 11.3.4 VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2017-2022) 11.3.5 VistaGen Therapeutics Recent Developments 11.4 Sanofi S.A 11.4.1 Sanofi S.A Company Details 11.4.2 Sanofi S.A Business Overview 11.4.3 Sanofi S.A Mental Disorder Treatment Introduction 11.4.4 Sanofi S.A Revenue in Mental Disorder Treatment Business (2017-2022) 11.4.5 Sanofi S.A Recent Developments 11.5 Novartis International AG 11.5.1 Novartis International AG Company Details 11.5.2 Novartis International AG Business Overview 11.5.3 Novartis International AG Mental Disorder Treatment Introduction 11.5.4 Novartis International AG Revenue in Mental Disorder Treatment Business (2017-2022) 11.5.5 Novartis International AG Recent Developments 11.6 Mylan N.V 11.6.1 Mylan N.V Company Details 11.6.2 Mylan N.V Business Overview 11.6.3 Mylan N.V Mental Disorder Treatment Introduction 11.6.4 Mylan N.V Revenue in Mental Disorder Treatment Business (2017-2022) 11.6.5 Mylan N.V Recent Developments 11.7 Amneal Pharmaceuticals LLC 11.7.1 Amneal Pharmaceuticals LLC Company Details 11.7.2 Amneal Pharmaceuticals LLC Business Overview 11.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Introduction 11.7.4 Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2017-2022) 11.7.5 Amneal Pharmaceuticals LLC Recent Developments 11.8 Cipla Ltd 11.8.1 Cipla Ltd Company Details 11.8.2 Cipla Ltd Business Overview 11.8.3 Cipla Ltd Mental Disorder Treatment Introduction 11.8.4 Cipla Ltd Revenue in Mental Disorder Treatment Business (2017-2022) 11.8.5 Cipla Ltd Recent Developments 11.9 Sun Pharmaceutical Industries Ltd 11.9.1 Sun Pharmaceutical Industries Ltd Company Details 11.9.2 Sun Pharmaceutical Industries Ltd Business Overview 11.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Introduction 11.9.4 Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2017-2022) 11.9.5 Sun Pharmaceutical Industries Ltd Recent Developments 11.10 Glenmark Pharmaceuticals Limited 11.10.1 Glenmark Pharmaceuticals Limited Company Details 11.10.2 Glenmark Pharmaceuticals Limited Business Overview 11.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Introduction 11.10.4 Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2017-2022) 11.10.5 Glenmark Pharmaceuticals Limited Recent Developments 11.11 Lupin Limited 11.11.1 Lupin Limited Company Details 11.11.2 Lupin Limited Business Overview 11.11.3 Lupin Limited Mental Disorder Treatment Introduction 11.11.4 Lupin Limited Revenue in Mental Disorder Treatment Business (2017-2022) 11.11.5 Lupin Limited Recent Developments 11.12 Janssen Pharmaceutica 11.12.1 Janssen Pharmaceutica Company Details 11.12.2 Janssen Pharmaceutica Business Overview 11.12.3 Janssen Pharmaceutica Mental Disorder Treatment Introduction 11.12.4 Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2017-2022) 11.12.5 Janssen Pharmaceutica Recent Developments 11.13 Bristol Myers Squibb 11.13.1 Bristol Myers Squibb Company Details 11.13.2 Bristol Myers Squibb Business Overview 11.13.3 Bristol Myers Squibb Mental Disorder Treatment Introduction 11.13.4 Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2017-2022) 11.13.5 Bristol Myers Squibb Recent Developments 11.14 Sumitomo Dainippon Pharma Co., Ltd 11.14.1 Sumitomo Dainippon Pharma Co., Ltd Company Details 11.14.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview 11.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Introduction 11.14.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2017-2022) 11.14.5 Sumitomo Dainippon Pharma Co., Ltd Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
List of Tables Table 1. Global Mental Disorder Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Medications Table 3. Key Players of Self-help Therapies Table 4. Global Mental Disorder Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Mental Disorder Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Mental Disorder Treatment Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Mental Disorder Treatment Market Share by Region (2017-2022) Table 8. Global Mental Disorder Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Mental Disorder Treatment Market Share by Region (2023-2028) Table 10. Mental Disorder Treatment Market Trends Table 11. Mental Disorder Treatment Market Drivers Table 12. Mental Disorder Treatment Market Challenges Table 13. Mental Disorder Treatment Market Restraints Table 14. Global Mental Disorder Treatment Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Mental Disorder Treatment Revenue Share by Players (2017-2022) Table 16. Global Top Mental Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2021) Table 17. Ranking of Global Top Mental Disorder Treatment Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Mental Disorder Treatment Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Mental Disorder Treatment Product Solution and Service Table 21. Date of Enter into Mental Disorder Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Mental Disorder Treatment Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Mental Disorder Treatment Revenue Market Share by Type (2017-2022) Table 25. Global Mental Disorder Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Mental Disorder Treatment Revenue Market Share by Type (2023-2028) Table 27. Global Mental Disorder Treatment Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Mental Disorder Treatment Revenue Share by Application (2017-2022) Table 29. Global Mental Disorder Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Mental Disorder Treatment Revenue Share by Application (2023-2028) Table 31. North America Mental Disorder Treatment Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Mental Disorder Treatment Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Mental Disorder Treatment Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Mental Disorder Treatment Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Mental Disorder Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Mental Disorder Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Mental Disorder Treatment Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Mental Disorder Treatment Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Mental Disorder Treatment Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Mental Disorder Treatment Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Mental Disorder Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Mental Disorder Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Mental Disorder Treatment Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Mental Disorder Treatment Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Mental Disorder Treatment Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Mental Disorder Treatment Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Mental Disorder Treatment Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Mental Disorder Treatment Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Mental Disorder Treatment Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Mental Disorder Treatment Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Mental Disorder Treatment Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Mental Disorder Treatment Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Mental Disorder Treatment Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Mental Disorder Treatment Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Mental Disorder Treatment Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Mental Disorder Treatment Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Mental Disorder Treatment Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Mental Disorder Treatment Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Mental Disorder Treatment Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Mental Disorder Treatment Market Size by Country (2023-2028) & (US$ Million) Table 61. Allergan Plc Company Details Table 62. Allergan Plc Business Overview Table 63. Allergan Plc Mental Disorder Treatment Product Table 64. Allergan Plc Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 65. Allergan Plc Recent Developments Table 66. Eli Lilly and Company Company Details Table 67. Eli Lilly and Company Business Overview Table 68. Eli Lilly and Company Mental Disorder Treatment Product Table 69. Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 70. Eli Lilly and Company Recent Developments Table 71. VistaGen Therapeutics Company Details Table 72. VistaGen Therapeutics Business Overview Table 73. VistaGen Therapeutics Mental Disorder Treatment Product Table 74. VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 75. VistaGen Therapeutics Recent Developments Table 76. Sanofi S.A Company Details Table 77. Sanofi S.A Business Overview Table 78. Sanofi S.A Mental Disorder Treatment Product Table 79. Sanofi S.A Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 80. Sanofi S.A Recent Developments Table 81. Novartis International AG Company Details Table 82. Novartis International AG Business Overview Table 83. Novartis International AG Mental Disorder Treatment Product Table 84. Novartis International AG Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 85. Novartis International AG Recent Developments Table 86. Mylan N.V Company Details Table 87. Mylan N.V Business Overview Table 88. Mylan N.V Mental Disorder Treatment Product Table 89. Mylan N.V Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 90. Mylan N.V Recent Developments Table 91. Amneal Pharmaceuticals LLC Company Details Table 92. Amneal Pharmaceuticals LLC Business Overview Table 93. Amneal Pharmaceuticals LLC Mental Disorder Treatment Product Table 94. Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 95. Amneal Pharmaceuticals LLC Recent Developments Table 96. Cipla Ltd Company Details Table 97. Cipla Ltd Business Overview Table 98. Cipla Ltd Mental Disorder Treatment Product Table 99. Cipla Ltd Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 100. Cipla Ltd Recent Developments Table 101. Sun Pharmaceutical Industries Ltd Company Details Table 102. Sun Pharmaceutical Industries Ltd Business Overview Table 103. Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Product Table 104. Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 105. Sun Pharmaceutical Industries Ltd Recent Developments Table 106. Glenmark Pharmaceuticals Limited Company Details Table 107. Glenmark Pharmaceuticals Limited Business Overview Table 108. Glenmark Pharmaceuticals Limited Mental Disorder Treatment Product Table 109. Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 110. Glenmark Pharmaceuticals Limited Recent Developments Table 111. Lupin Limited Company Details Table 112. Lupin Limited Business Overview Table 113. Lupin Limited Mental Disorder Treatment Product Table 114. Lupin Limited Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 115. Lupin Limited Recent Developments Table 116. Janssen Pharmaceutica Company Details Table 117. Janssen Pharmaceutica Business Overview Table 118. Janssen Pharmaceutica Mental Disorder Treatment Product Table 119. Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 120. Janssen Pharmaceutica Recent Developments Table 121. Bristol Myers Squibb Company Details Table 122. Bristol Myers Squibb Business Overview Table 123. Bristol Myers Squibb Mental Disorder Treatment Product Table 124. Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 125. Bristol Myers Squibb Recent Developments Table 126. Sumitomo Dainippon Pharma Co., Ltd Company Details Table 127. Sumitomo Dainippon Pharma Co., Ltd Business Overview Table 128. Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Product Table 129. Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2017-2022) & (US$ Million) Table 130. Sumitomo Dainippon Pharma Co., Ltd Recent Developments Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Mental Disorder Treatment Market Share by Type: 2021 VS 2028 Figure 2. Medications Features Figure 3. Self-help Therapies Features Figure 4. Global Mental Disorder Treatment Market Share by Application: 2021 VS 2028 Figure 5. Depression Case Studies Figure 6. Bipolar Disorder Case Studies Figure 7. Schizophrenia Case Studies Figure 8. Dementia Case Studies Figure 9. Post-traumatic Stress Disorder Case Studies Figure 10. Others Case Studies Figure 11. Mental Disorder Treatment Report Years Considered Figure 12. Global Mental Disorder Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Mental Disorder Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Mental Disorder Treatment Market Share by Region: 2021 VS 2028 Figure 15. Global Mental Disorder Treatment Market Share by Players in 2021 Figure 16. Global Top Mental Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorder Treatment as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Mental Disorder Treatment Revenue in 2021 Figure 18. North America Mental Disorder Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America Mental Disorder Treatment Market Size Market Share by Type (2017-2028) Figure 20. North America Mental Disorder Treatment Market Size Market Share by Application (2017-2028) Figure 21. North America Mental Disorder Treatment Market Size Share by Country (2017-2028) Figure 22. United States Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Mental Disorder Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe Mental Disorder Treatment Market Size Market Share by Type (2017-2028) Figure 26. Europe Mental Disorder Treatment Market Size Market Share by Application (2017-2028) Figure 27. Europe Mental Disorder Treatment Market Size Share by Country (2017-2028) Figure 28. Germany Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Mental Disorder Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific Mental Disorder Treatment Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific Mental Disorder Treatment Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific Mental Disorder Treatment Market Size Share by Region (2017-2028) Figure 38. China Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America Mental Disorder Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America Mental Disorder Treatment Market Size Market Share by Type (2017-2028) Figure 46. Latin America Mental Disorder Treatment Market Size Market Share by Application (2017-2028) Figure 47. Latin America Mental Disorder Treatment Market Size Share by Country (2017-2028) Figure 48. Mexico Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Mental Disorder Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa Mental Disorder Treatment Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa Mental Disorder Treatment Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa Mental Disorder Treatment Market Size Share by Country (2017-2028) Figure 54. Turkey Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE Mental Disorder Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Allergan Plc Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 58. Eli Lilly and Company Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 59. VistaGen Therapeutics Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 60. Sanofi S.A Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 61. Novartis International AG Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 62. Mylan N.V Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 63. Amneal Pharmaceuticals LLC Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 64. Cipla Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 65. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 66. Glenmark Pharmaceuticals Limited Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 67. Lupin Limited Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 68. Janssen Pharmaceutica Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 69. Bristol Myers Squibb Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 70. Sumitomo Dainippon Pharma Co., Ltd Revenue Growth Rate in Mental Disorder Treatment Business (2017-2022) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed
Allergan Plc Eli Lilly and Company VistaGen Therapeutics Sanofi S.A Novartis International AG Mylan N.V Amneal Pharmaceuticals LLC Cipla Ltd Sun Pharmaceutical Industries Ltd Glenmark Pharmaceuticals Limited Lupin Limited Janssen Pharmaceutica Bristol Myers Squibb Sumitomo Dainippon Pharma Co., Ltd
  • PRICE
  • $4900
    $9800
    $7350
    Buy Now

Our Clients